China’s Seven Listed Pet Companies Posted 15% Revenue Growth but a 47% Net-Profit Collapse in H1 2026

Executive Summary: Seven China-listed pet companies, led by 乖宝宠物 (301498.SZ), 中宠股份 (002891.SZ), 佩蒂股份 (300673.SZ), 依依股份 (001206.SZ), 源飞宠物 (001222.SZ), 天元宠物 (301335.SZ), and 路斯股份 (832419.NQ), reported combined H1 2026 revenue of ¥11.386 billion (+15.15% YoY) but only ¥482 million in attributable net profit (-46.75% YoY). The result, published across the listed-company filings on the Shenzhen and Beijing exchanges in August 2026 and synthesised by 国际金融报 and 腾讯财经 on 12 September 2026, formally places the China pet industry in a “grow-revenue-lose-profit” phase. The structural cause is sales-expense acceleration on owned-brand build-out, RMB appreciation against the USD on the export-OEM order book (five of the seven derive >50% revenue overseas), and US tariff friction — not a top-line demand collapse. The pet consumer market in China remains positive at ¥336.5 billion in 2026 (+4.3% YoY) per the 亚宠研究院 Pet Industry Blue Book 2026; the issue is margin, not demand.

Key Facts

Topic

China pet industry H1 2026 profit compression

Country

China

Industry

Pet food, accessories, supplies (manufacturing + brand)

Category

Market trends / margins

Event

H1 2026 half-year results of seven China-listed pet names

Date

2026-09-11 to 2026-09-12 (results press cycle)

Location

Mainland China; A-share (Shenzhen + Beijing exchanges)

Source

巨潮资讯网 CNINFO H1 2026 半年度报告 (批次披露 2026-08-25 → 2026-08-30); 亚宠研究院 Pet Industry Blue Book 2026 (data referenced)

What Happened

In the half-year results cycle ending 30 June 2026, seven China A-share listed pet companies — collectively the most complete financial proxy for the china pet industry — reported a uniform pattern of revenue growth paired with profit decline. Aggregate attributable net profit came in at ¥482 million, down 46.75% from the same period in 2025, even as combined revenue rose to ¥11.386 billion (+15.15% YoY). Per filing disclosures summarised by 国际金融报 (12 September 2026), the smallest profit decline was 18.56% at one firm; 佩蒂股份 posted the deepest fall at -69.25%.

The headline numbers at the top of the table belong to the two firms above ¥3 billion H1 revenue: 乖宝宠物 (Maifudi, Feligerate, Baff brands) at ¥3.543 billion (+10.0% YoY) with attributable net profit below ¥200 million; and 中宠股份 (Wanpy, Toptrees, Zhen Zhi brands) at ¥3.281 billion (+34.9%) with net profit below ¥200 million and a recorded ¥123.556 million increase in financial expense driven by RMB/USD FX losses.

Importantly, the seven-company aggregate is the first half-year print in which every growing-revenue listed company also produced declining net profit. The implied industry-wide margin compression is structural, not company-specific.

Background

For the prior six years, the China pet industry was a textbook growth curve: rising ownership, rising per-pet spend, and a structural arbitrage between low-cost contract-manufacturing capacity and a still-developing consumer brand market. Six of the seven originated as OEM manufacturers servicing US, UK, German, and Australian retail labels before building their own owned brands.

The 2022-2025 period was capacity build-out for export, with the leading names building overseas plants in Cambodia, Vietnam, and the US to absorb tariff diversion. The H1 2026 shift is a second move: a coordinated pivot toward owned brand investment in China. Sales-expense ratios across the cohort climbed materially — 乖宝 set a 24.28% ratio (+3.1 pp YoY; 同花顺 iFinD), spending ¥860 million on marketing.

Industry Context

Beyond the seven-company aggregate, two macro indicators printed in early September 2026 confirm the rotation is volume-to-value rather than market decline. The 亚宠研究院 (Yà Chǒng Research Institute) Pet Industry Blue Book 2026 projects the 2026 China pet consumer market at ¥336.5 billion, +4.3% YoY versus +5.2% in 2025. Within that base, dog and cat population growth has decelerated to +0.89% annually — cats at 104 million grew at +0.8% versus +4.5% in 2021. Per-pet spend, however, accelerated: average annual spend on a single dog reached ¥3,006 (+1.5% YoY); on a single cat ¥2,085 (+3.2%). Industry’s working label for this combination — population flat-to-shrinking while per-owner spend rises — is the pet humanization trend, a structural setting in which owners shift spending from “more food for more pets” to “better food for the pets I have.”

Distribution-side concentration is the second story. Online pet food sales data from brokerage analysis for H1 2026 show the top-five brand share (CR5) at 28.0%, up 5.4 percentage points in six months; CR10 at 41.6%; CR20 at 55.6%. The 2026 618 e-commerce top-10 brand list, as reported across multiple China e-trade outlets, contained no new entrants for the first time on record.

Market & Business Impact

For B2B buyers and suppliers, the H1 2026 print carries three operational implications. First, OEM partners globally should expect continued RMB-driven margin pressure: with the renminbi trading roughly 5.9% stronger versus the USD year-to-date 2026, every dollar-denominated contract converts to fewer renminbi at receipt. Second, China-based owned-brand management is now an arms race — the seven names collectively are spending at sales-expense ratios that assume a multi-year battle for share, not a single-quarter promotion. Third, the consolidation pressure is real: with no new entrants in the 618 top-10 and CR5 jumping 5.4 points in six months, smaller brands in the ¥100M-¥500M range are now mid-cycle acquisition targets. The first formal instance of this is a separate A-share deal pending SZSE review (the Tianyuan Pet / Taotong Tech combination, also queued for publication by GPI), the first China-listed pet company to buy a brand channel at scale.

Companies & Brands Involved

The seven A-share listed names, with brand portfolios and H1 2026 performance:

• 乖宝宠物 (301498.SZ) — Maifudi, Feligerate, Baff; 24.28% sales-expense ratio.
• 中宠股份 (002891.SZ) — Wanpy, Toptrees, Zhen Zhi; ¥3.281B revenue (+34.9%); +46% sales-expense growth.
• 佩蒂股份 (300673.SZ) — Vietnam chew plants; -69.25% net-profit decline.
• 依依股份 (001206.SZ) — Hygiene/absorbent products.
• 源飞宠物 (001222.SZ) — Pet toys and apparel; +70%-plus sales-expense growth.
• 天元宠物 (301335.SZ) — Pet accessories wholesale and brand.
• 路斯股份 (832419.NQ) — Pet treats and snacks.

Pet apparel wholesale margins within the listed portfolios are visibly contracting; brand-level splits are in each 半年度报告.

Data & Evidence

Headline figures (single-source: 巨潮 CNINFO H1 2026 filings, batch 2026-08-25 → 2026-08-30):

• Combined revenue: ¥11.386 billion (+15.15% YoY)
• Combined attributable net profit: ¥482 million (-46.75% YoY)
• Companies with revenue growth: 6 of 7 (excluding one flat-line)
• Companies with net-profit decline: 7 of 7
• 5 of 7 derive >50% revenue from overseas contract manufacturing
• 乖宝 Q2 sales-expense ratio: 24.28% (+3.1 pp YoY)
• 中宠 H1 sales expense: ¥435 million (+46% YoY)

亚宠 Blue Book 2026 (released August 2026, cited via Tencent and Sina Finance reports in early September 2026):

• 2026 China pet consumer market forecast: ¥336.5 billion (+4.3%)
• Dog + cat population growth: +0.89% YoY
• Cat population: 104 million (+0.8% YoY vs +4.5% in 2021)
• Per-dog annual spend: ¥3,006 (+1.5%)
• Per-cat annual spend: ¥2,085 (+3.2%)

Online concentration (brokerage calculation, see China equity research notes 2026-09-09 onwards):

• CR5: 28.0% (+5.4 pp vs H2 2025)
• CR10: 41.6%
• CR20: 55.6%

What This Means for the Pet Industry

The H1 2026 print is the formal start of a margin-led, not volume-led, China pet industry cycle. The acceleration in sales expense across all growing names is the clearest signal that owned-brand investment is now the strategic priority, even at the cost of mid-cycle profit — a deliberate trade-off to capture CR5 share in a market where 618 top-10 churn has stopped. For B2B buyers, the practical implication is two-track procurement: cost-sensitive OEM ordering remains in volume, but any new product line that requires Chinese co-development or contracted pet apparel wholesale should price in a margin compression floor of 5-8 percentage points for the partner. The structural setup — premiumisation as pet premiumization, family-as-society pet humanization trend, per-pet spend rising at the cat side — is not threatened, but the financialised winners are the ones with the deepest owned-brand lines and disciplined FX hedging, not the ones still chasing OEM volume. GPI sees this as the most consequential single cohort print of the decade, precisely because premiumization and humanization have not been the profit driver so far — they have been the volume-growth story, and that has just inverted.

Key Takeaways

• Seven China-listed pet companies reported ¥11.386 billion H1 2026 revenue (+15.15%) but only ¥482 million net profit (-46.75%), with all growing-revenue firms also posting profit declines.
• Sales-expense ratios at the leaders (乖宝 24.28% / 中宠 +46% sales-expense growth) signal a deliberate owned-brand investment cycle, not demand weakness.
• Five of seven derive >50% revenue from overseas contract manufacturing, making RMB appreciation and US tariff exposure the structural profit headwind.
• The 亚宠 Blue Book 2026 confirms volume-to-value rotation: dog/cat population growth at +0.89%, but per-pet spend up 1.5-3.2% YoY — the textbook pet humanization trend, paired with rising pet premiumization as owners trade up to functional and prescription tiers.
• Online pet food CR5 hit 28.0% (+5.4 pp in six months); 618 top-10 had no new entrants for the first time on record, confirming small-brand acquisition pressure.
• The first listed-company-to-channel M&A of this consolidation cycle is now formally queued (Tianyuan / Taotong, RMB 640 million, SZSE M&A Review Committee approved 2026-09-09).

Frequently Asked Questions

Sources

1. Primary — Seven H1 2026 半年度报告 (乖宝 301498, 中宠 002891, 佩蒂 300673, 依依 001206, 源飞 001222, 天元 301335, 路斯 832419), 巨潮资讯网 CNINFO, batch 2026-08-25 → 2026-08-30.
2. Secondary — 国际金融报 / Tencent News, “净利近乎腰斩！7家上市宠企半年报集体’失血'”, 2026-09-12 00:35, https://news.qq.com/rain/a/20260912A00I7400.
3. Secondary — 网易 / 金融界, “7家上市宠物公司H1财报解读”, 2026-09-12, https://dy.163.com/article/L6JHR3FK0519QIKK.html.
4. Secondary — 新京报贝壳财经, 2026-09-11, https://k.sina.cn/article_5953466437_162dab0450670bc4d.html.
5. Data — 亚宠研究院 Pet Industry Blue Book: 2026 China Pet Industry Development Report, released August 2026 (cited in coverage above).

Related News & GPI Data

• GPI Knowledge: Companies Directory — browse Chinese pet manufacturers and brand owners.
• GPI Knowledge: Compare Tool — benchmark pet food brands on nutrition, sourcing, and pricing.
• GPI Knowledge: China Pet Brand Rankings 2026.
• GPI News (queued): Tianyuan Pet RMB 640M acquisition of Taotong Tech clears SZSE M&A Review (2026-09-09).
• GPI News: China pet brand 半年报 sector-wide analysis (2026-09-12).